Rice Hall James & Associates’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-213,748
| Closed | -$2.96M | – | 312 |
|
|
2021
Q2 | $2.96M | Sell |
213,748
-68,992
| -24% | -$954K | 0.11% | 150 |
|
|
2021
Q1 | $4.13M | Buy |
282,740
+72,245
| +34% | +$1.06M | 0.13% | 123 |
|
|
2020
Q4 | $3.66M | Sell |
210,495
-73,866
| -26% | -$1.28M | 0.13% | 126 |
|
|
2020
Q3 | $5.22M | Sell |
284,361
-166,571
| -37% | -$3.05M | 0.21% | 94 |
|
|
2020
Q2 | $8.05M | Buy |
450,932
+56,004
| +14% | +$1M | 0.35% | 81 |
|
|
2020
Q1 | $6.41M | Sell |
394,928
-302,625
| -43% | -$4.91M | 0.36% | 82 |
|
|
2019
Q4 | $12.6M | Sell |
697,553
-8,134
| -1% | -$146K | 0.42% | 92 |
|
|
2019
Q3 | $14.3M | Buy |
+705,687
| New | +$14.3M | 0.51% | 78 |
|